Story excerpt provided by Crain’s Cleveland Business.
Written by Lydia Coutré.
University Hospitals Harrington Discovery Institute and the Alzheimer’s Drug Discovery Foundation (ADDF) are expanding their collaboration to accelerate the translation of promising research for Alzheimer’s disease. The two organizations, which have partnered since 2014, will jointly market and administer a new award program for academic researchers, in the hopes of advancing Alzheimer’s disease drug discovery projects in academic institutions nationwide, according to a news release.
Originally published January 11, 2017.